MINIPRESS TABLET 2MG

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
11-04-2019
Ciri produk Ciri produk (SPC)
03-05-2018

Bahan aktif:

PRAZOSIN HYDROCHLORIDE

Boleh didapati daripada:

PFIZER (MALAYSIA) SDN. BHD.

INN (Nama Antarabangsa):

PRAZOSIN HYDROCHLORIDE

Unit dalam pakej:

250Tablet Tablets; 100Tablet Tablets

Dikeluarkan oleh:

PFIZER AUSTRALIA PTY. LTD.

Risalah maklumat

                                Pfizer Confidential
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
MINIPRESS
® TABLET
Prazosin Hydrochloride (1 mg, 2 mg & 5 mg)
1
PLD TITLE:
MINIPRESS
PLD DATE:
04 April 2019
COUNTRY:
Malaysia
REFERENCE DOCUMENT:
Malaysia LPD dated 13 April 2018
REASON FOR CHANGE
:
To align as per new template and the HA approved LPD
To update PIL as per HA Request dated 18-Dec-2018
To align as per MINIPRESS PMB PIL
To update PRH address
Pfizer Confidential
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
MINIPRESS
® TABLET
Prazosin Hydrochloride (1 mg, 2 mg & 5 mg)
2
WHAT IS IN THIS LEAFLET
1.
What MINIPRESS is used for
2.
How MINIPRESS works
3.
Before you use MINIPRESS
4.
How to use MINIPRESS
5.
While you are using it
6.
Side effects
7.
Storage and Disposal of
MINIPRESS
8.
Product Description
9.
Manufacturer and Product
Registration Holder
10.
Date of revision
11.
Serial Number
WHAT MINIPRESS IS USED FOR
MINIPRESS is one of a group of
medicines called alpha-blockers.
It is usually used to treat high blood
pressure (hypertension). It may also be
used to treat heart failure (left ventricle-
related), painful cold fingers (Raynaud’s
Disease) or mild enlargement of the
prostate gland (Benign prostatic
hyperplasia) in men.
HOW MINIPRESS WORKS
In patients with high blood pressure
(hypertension) MINIPRESS works by
relaxing blood vessels (more on
peripheral vessels) so that blood passes
through them more easily. It can be used
alone or in combination with other drugs
used to treat hypertension.
In patients with heart failure,
MINIPRESS works by relaxing the main
blood vessels of the heart, allowing the
heart to pump blood more easily.
MINIPRESS is usually used in heart
failure when other drugs are either no
longer working or have not worked at all.
In patients with Raynaud’s Disease the
treatment relaxes blood vessels in the
hands, so blood can reach the fingers
more easily. This helps to prevent
coldness and stiffness.
In patients with Benign Prostatic
Hyperplasia, enlargement of the prostate
gland, the medicine is taken to
                                
                                Baca dokumen lengkap
                                
                            

Ciri produk

                                Pfizer Confidential
LPD Title : MINIPRESS
LPD Date : 13 April 2018
Country : Malaysia
References : CDS v4 dated 11 November 2014
Reason : To include product description information as per BoH directive
1. NAME OF THE MEDICINAL PRODUCT
MINIPRESS
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each prazosin hydrochloride tablet contains the equivalent of 1 mg, 2 mg or 5 mg of
prazosin-free base.
3. PHARMACEUTICAL FORM
Tablets
Minipress 1 mg: An orange capsule shaped tablet with 'MNP 1' on one side and score line on
the other.
Minipress 2 mg: A round white tablet with 'MNP score line 2' on one side and plain on the
other.
Minipress 5 mg: A white diamond shaped tablet with 'MNP score line 5' debossing on one
side and score line on the other.
4. CLINICAL PARTICULARS
4.1 Therapeutic Indications
Hypertension
Prazosin hydrochloride is indicated in the treatment of all grades of essential (primary)
hypertension and all grades of secondary hypertension of varied etiology. It can be used as
the initial and sole agent or it may be employed in a treatment program in conjunction with a
diuretic and/or other antihypertensive drugs, as needed, for proper patient response.
Left Ventricular Failure
Prazosin hy drochloride is indicated in the treatment of left ventricular failure. Prazosin
hydrochloride may be added to the therapeutic regimen in patients who have not shown a
satisfactory response or who have become refractory to conventional therapy with diuretic s,
with or without cardiac glycosides.
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Bahasa Melayu 11-04-2019

Cari amaran yang berkaitan dengan produk ini